Search Results

You are looking at 71 - 80 of 1,145 items for :

  • "characteristics" x
  • All content x
Clear All
Full access

Stephen R. Grant, Benjamin D. Smith, Lauren E. Colbert, Qunyh-Nhu Nguyen, James B. Yu, Steven H. Lin, and Aileen B. Chen

(1) assess the frequency of quality measure–concordant radiation for bone metastases as per NQF 1822; (2) describe variation in compliance by tumor, patient, and treatment characteristics; and (3) explore and consider the value, shortcomings, and

Full access

Lydia T. Madsen, Deborah A. Kuban, Seungtaek Choi, John W. Davis, Jeri Kim, Andrew K. Lee, Delora Domain, Larry Levy, Louis L. Pisters, Curtis A. Pettaway, John F. Ward, Christopher Logothetis, and Karen E. Hoffman

conducted using SAS 9.2 (Cary, North Carolina). Results Patient Characteristics A total of 1370 men with localized prostate cancer were seen at the MPCC between 2004 and 2008 and subsequently received treatment at MD Anderson. The median age at

Full access

Lisa I. Iezzoni, Sowmya R. Rao, Nicole D. Agaronnik, and Areej El-Jawahri

) age at cancer diagnosis for persons with versus without preexisting disability, and (4) associations between cancer diagnosis and preexisting disability after adjusting for sociodemographic characteristics and selected risk factors. Methods Data We

Full access

Gary S. Rogers

reported on the use of a hematoporphyrin derivative to treat a person with metastatic chest wall breast cancer. Table 1 lists the characteristics of 3 photosensitizers: porfimer sodium (Photofrin), 5-aminolevulinic acid (ALA), and mTHPC ( meso -tetra

Full access

Amy Waller, Rob Sanson-Fisher, Nicholas Zdenkowski, Charles Douglas, Alix Hall, and Justin Walsh

to be able to die in the location of my choice (eg, at home, hospital, hospice, other),” with options ranging from strongly disagree to strongly agree. Sociodemographic and Clinical Characteristics: Sociodemographic and clinical characteristics

Full access

En Cheng, Peiyin Hung, and Shi-Yi Wang

characteristics, and comorbidities were associated with survival among patients with HCC. Methods Data Source and Population We established a population-based retrospective cohort study using the SEER-Medicare linked database. The SEER program is an authoritative

Full access

Adam J. Kole, John M. Stahl, Henry S. Park, Sajid A. Khan, and Kimberly L. Johung

Station, TX). Table 1. Patient Cohort Demographic and Clinicopathologic Characteristics Results Within the NCDB, we identified 3,370 patients from 2004 to 2012 with histologically confirmed clinical T1N0 anal canal carcinoma

Full access

Antonio Di Meglio, Nancy U. Lin, Rachel A. Freedman, William T. Barry, Eric P. Winer, and Ines Vaz-Luis

−. Patients with >1 disease site were assigned to the category of the first site listed, according to a prespecified ranking system defined by importance. Table 1. Patient Demographics and Clinicopathologic Characteristics (n=302) Central

Full access

Estanislao Arana, Francisco M. Kovacs, Ana Royuela, Beatriz Asenjo, Fatima Nagib, Sandra Pérez-Aguilera, María Dejoz, Alberto Cabrera-Zubizarreta, Yolanda García-Hidalgo, Ana Estremera, and for the Spanish Back Pain Research Network Task Force for the Improvement of Inter-Disciplinary Management of Spinal Metastasis

years. Table 1 also shows the characteristics of the 203 patients whose clinical histories and images were selected for the study and of the 25 readers who interpreted their data. Table 1. Sample Characteristics As Table 2 shows, interobserver

Full access

Erin E. Hahn, Michael K. Gould, Corrine E. Munoz-Plaza, Janet S. Lee, Carla Parry, and Ernest Shen

adjusted for multiple pairwise comparisons between comorbidity classes by using the Bonferroni correction. Table 1. Patient Characteristics, Cancer Treatment, and Comorbidities Results We identified 7,803 patients with CRC ( Table 1